🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This project will use literature analysis, expert research, real-world data...
Status
Active Not Recruiting
Location
Rui Yang,MD
Start Date
2023-04-01
Trial ID
NCT06106789
Treatments Being Tested
The purpose of this study is to evaluate the effect of tobramycin inhalatio...
Status
Completed
Location
North West Clinics
Start Date
2016-08-13
Trial ID
NCT02657473
Treatments Being Tested
A double-blind, active-controlled, multiple-ascending dose, safety study of...
Status
Completed
Location
Tucson Cystic Fibrosis Center
Start Date
2024-04-01
Trial ID
NCT06016088
Treatments Being Tested
People with bronchiectasis are prone to Pseudomonas aeruginosa (PA) infecti...
Status
Completed
Location
Anhui Chest Hospital
Start Date
2023-10-18
Trial ID
NCT06093191
A major factor in the respiratory health of Cystic Fibrosis (CF) participan...
Status
Completed
Location
Multiple Locations
Start Date
2012-02-29
Trial ID
NCT01315678
This study compares pharmacokinetic profiles of tobramycin delivered by Tob...
Status
Completed
Location
Quotient Clinical
Start Date
2014-07
Trial ID
NCT02207426
Treatments Being Tested
The primary objective of this study is to evaluate the safety and efficacy ...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2012-12
Trial ID
NCT01641822
Treatments Being Tested
To assess whether the inhalative combination of Tobramycin/Colistin is more...
Status
Completed
Location
Multiple Locations
Start Date
2014-03-11
Trial ID
NCT03341741
Treatments Being Tested
The purpose of this study was to assess the comparative safety and effectiv...
Status
Completed
Location
Multiple Locations
Start Date
2008-08
Trial ID
NCT00757237
Treatments Being Tested
Inhaled tobramycin is a Cystic Fibrosis Foundation recommended effective tr...
Status
Terminated
Location
Rush University Medical Center
Start Date
2013-10-10
Trial ID
NCT02038803
Treatments Being Tested